Appropriation for psilocybin research.

HB 1166 allocates state funds from the general budget to establish a dedicated therapeutic psilocybin research fund. This bill directly affects researchers and institutions conducting clinical studies on psilocybin for medical purposes, providing them with dedicated funding. The key provision is the specific appropriation from the state general fund to support research into psilocybin's therapeutic applications, without altering existing laws or creating new regulations. The bill is procedural in nature, focusing solely on funding allocation rather than policy changes.